Positive on Ahuzat Bayit

TASE closes higher as insurance, biomed sectors lead gains

TA-35 gained 1.84%, TA-90 rose about 2.58%, and TA-125 added about 1.97% • The euro fell about 0.93% to NIS 3.52, while the dollar weakened about 0.95% to NIS 3.15

The Tel Aviv Stock Exchange
The Tel Aviv Stock Exchange | Photo: Roy Alima, Flash90

Today (Monday), the Tel Aviv Stock Exchange (TASE) closed higher, with the TA-35 gaining 1.84%, the TA-90 rising about 2.58%, and the TA-125 gaining about 1.97%.

In addition, the TA-Banks index weakened about 0.24%. By contrast, the TA-Biomed index rose about 3.4%, while TA-Insurance gained 3.89%.

Partner shares rose 6.48% following the company's reports. In addition, Shemen Real Estate shares surged 19.05%.

Evogene shares fell 12.41%. In addition, Epitomee Medical shares lost about 6.17%.

Reports

Partner (PTNR ▲6.57%) published its financial results for the third quarter of 2026 this morning (Monday), reporting increases in revenue and net profit. The company's revenue totaled NIS 829 million, up 5.7% from the corresponding period last year.

Operating profit totaled NIS 148 million, while net profit rose 12% to NIS 101 million. Looking at the first nine months of the year, operating profit rose about 6% to NIS 350 million. By contrast, the company's adjusted free cash flow fell sharply by 66% to NIS 43 million.

In addition, Next Vision (NXSN ▲10.43%), (Nexen), which develops and manufactures stabilized imaging systems for drones and light aircraft, today wrapped up a stellar third quarter of 2026, with continued growth momentum and a clear improvement in profitability metrics.

The company's results reflect growing global demand for advanced imaging solutions in the defense and civilian markets, while demonstrating exceptional operating efficiency and economies of scale that continue to support unusually high profit margins in the technology sector.

Israeli biopharmaceutical company Kamada (KMDA ▲3.80%), which is controlled by the FIMI fund, also wrapped up an especially strong third quarter and reported record results for the first nine months of 2026.

Following its operating and financial performance and growing demand for the company's products, Kamada raised its revenue and profitability forecast for the full year and expects double-digit growth momentum to continue into 2027.

Furthermore, consumer products and distribution group Diplomat (DIPL ▲2.99%) Holdings continues to implement its strategy of expanding its international operations and reported the signing of a binding agreement to acquire a controlling stake (60%) in two private companies operating in consumer goods distribution (FMCG) in Mexico.

The initial purchase price is about $45 million (about NIS 142 million), alongside a performance-based future consideration mechanism and a mutual option mechanism to acquire full ownership in the future.

Foreign Exchange

Finally, the euro fell about 0.93% to NIS 3.52, while the dollar weakened about 0.95% to NIS 3.15.

Key takeaways

  • The Tel Aviv Stock Exchange closed higher, led by gains in TA-Insurance and TA-Biomed, while TA-Banks edged down about 0.24%.
  • Partner shares rose after the company reported third-quarter 2026 results, with revenue of NIS 829 million and net profit of NIS 101 million.
  • Next Vision reported a strong third quarter of 2026 and said its results reflect continued growth momentum and improved profitability.
  • Kamada also reported record results for the first nine months of 2026 and raised its full-year revenue and profitability forecast.
  • Diplomat said it signed an agreement to buy a 60% controlling stake in two consumer goods distribution companies in Mexico for about $45 million.

Questions and answers

Why did Partner shares rise today?
Partner rose after reporting third-quarter 2026 results showing higher revenue and net profit. The company said revenue reached NIS 829 million and net profit rose 12% to NIS 101 million.
Which sectors led the gains on the TASE?
TA-Biomed rose about 3.4% and TA-Insurance gained 3.89%, leading the market higher. TA-35, TA-90 and TA-125 also finished in positive territory.
What did Kamada report?
Kamada reported record results for the first nine months of 2026. The company also raised its revenue and profitability forecast for the full year and expects double-digit growth momentum to continue into 2027.

Share this story

About the writer

Shai Nogai

Writes for TV10, Israel’s economic channel. This story was translated from the original Hebrew.

More stories by Shai Nogai

More for you